8B98
| |
8B96
| |
7Q3F
| Bromodomain-containing 4 BD1 in complex with the inhibitor CRCM5484 | 分子名称: | 2-[[11-ethanoyl-4-(furan-2-ylmethyl)-3-oxidanylidene-8-thia-4,6,11-triazatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7),5-trien-5-yl]sulfanyl]-~{N}-(2-methylpyridin-3-yl)ethanamide, Bromodomain-containing protein 4 | 著者 | Carrasco, K, Betzi, S, Morelli, X. | 登録日 | 2021-10-27 | 公開日 | 2022-04-20 | 最終更新日 | 2024-01-31 | 実験手法 | X-RAY DIFFRACTION (1.21 Å) | 主引用文献 | CRCM5484: A BET-BDII Selective Compound with Differential Anti-leukemic Drug Modulation J.Med.Chem., 65, 2022
|
|
7Q5O
| Bromodomain-containing 2 BD2 in complex with the inhibitor CRCM5484 | 分子名称: | 1,2-ETHANEDIOL, 2-[[11-ethanoyl-4-(furan-2-ylmethyl)-3-oxidanylidene-8-thia-4,6,11-triazatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7),5-trien-5-yl]sulfanyl]-~{N}-(2-methylpyridin-3-yl)ethanamide, Bromodomain-containing protein 2 | 著者 | Carrasco, K, Betzi, S, Morelli, X. | 登録日 | 2021-11-04 | 公開日 | 2022-04-20 | 最終更新日 | 2024-01-31 | 実験手法 | X-RAY DIFFRACTION (1.519 Å) | 主引用文献 | CRCM5484: A BET-BDII Selective Compound with Differential Anti-leukemic Drug Modulation J.Med.Chem., 65, 2022
|
|
8AEL
| SYNJ2BP complex with a synthetic Vangl2 peptide (3mer). | 分子名称: | CALCIUM ION, GLY-GLY-GLY-THR-SER-VAL, GLYCEROL, ... | 著者 | Carrasco, K, Cousido Siah, A, Gogl, G, Betzi, S, McEwen, A, Kostmann, C, Trave, G. | 登録日 | 2022-07-13 | 公開日 | 2023-08-16 | 最終更新日 | 2024-09-04 | 実験手法 | X-RAY DIFFRACTION (2.2 Å) | 主引用文献 | SYNJ2BP PDZ domain in complex with a synthetic Vangl2 peptide. To Be Published
|
|
7R2M
| SYNJ2BP complex with a synthetic Vangl2 peptide (9mer). | 分子名称: | 2-{2-[2-(2-{2-[2-(2-ETHOXY-ETHOXY)-ETHOXY]-ETHOXY}-ETHOXY)-ETHOXY]-ETHOXY}-ETHANOL, CALCIUM ION, GLYCEROL, ... | 著者 | Carrasco, K, Cousido Siah, A, Gogl, G, Betzi, S, McEwen, A, Kostmann, C, Trave, G. | 登録日 | 2022-02-04 | 公開日 | 2023-05-17 | 最終更新日 | 2024-09-04 | 実験手法 | X-RAY DIFFRACTION (2.4 Å) | 主引用文献 | PDZome-wide and structural characterization of the PDZ-binding motif of VANGL2. Biochim Biophys Acta Proteins Proteom, 1872, 2024
|
|
7R2T
| SYNJ2BP complex with a phosphorylated Vangl2 peptide at the P-1 position. | 分子名称: | CALCIUM ION, GLYCEROL, Synaptojanin-2-binding protein,Annexin, ... | 著者 | Carrasco, K, Cousido Siah, A, Gogl, G, Betzi, S, McEwen, A, Kostmann, C, Trave, G. | 登録日 | 2022-02-05 | 公開日 | 2023-05-17 | 最終更新日 | 2024-09-04 | 実験手法 | X-RAY DIFFRACTION (2.5 Å) | 主引用文献 | PDZome-wide and structural characterization of the PDZ-binding motif of VANGL2. Biochim Biophys Acta Proteins Proteom, 1872, 2024
|
|
6FO5
| FIRST DOMAIN OF HUMAN BROMODOMAIN BRD4 IN COMPLEX WITH INHIBITOR #17 | 分子名称: | 1,2-ETHANEDIOL, Bromodomain-containing protein 4, ~{N}-[[4-[[7-ethyl-2,6-bis(oxidanylidene)purin-3-yl]methyl]phenyl]methyl]-2-oxidanylidene-1,3,4,5-tetrahydro-1-benzazepine-7-sulfonamide | 著者 | Raux, B, Betzi, S. | 登録日 | 2018-02-06 | 公開日 | 2018-06-20 | 最終更新日 | 2024-01-17 | 実験手法 | X-RAY DIFFRACTION (0.95 Å) | 主引用文献 | Integrated Strategy for Lead Optimization Based on Fragment Growing: The Diversity-Oriented-Target-Focused-Synthesis Approach. J. Med. Chem., 61, 2018
|
|
6FNX
| |